Publication | Closed Access

Discovery of quinazolinyl-containing benzamides derivatives as novel HDAC1 inhibitors with in vitro and in vivo antitumor activities

Medicinal ChemistryNovel Hdac1 InhibitorsVivo Antitumor ActivitiesMedicineDrug DiscoveryPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentQuinazolinyl-containing Benzamides DerivativesPharmacologyBiomolecular Engineering